Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Accepted/In Press date: 24 October 2022

e-pub ahead of print date: 10 November 2022

Published date: 3 February 2023

Additional Information: Funding Information: AV and MD acknowledge the European Reference Network for Rare Solid Adult Cancers (EURACAN) for valuable input and networking. Manuscript editing support was provided by Richard Lutz and Claire Bramley ( ESMO Guidelines staff) and Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd (KMC); this support was funded by ESMO . Nathan Cherny, Chair of the ESMO-MCBS Working Group, Urani Dafni, ESMO-MCBS Working Group Member/Frontier Science Foundation Hellas and Giota Zygoura of Frontier Science Foundation Hellas provided review and validation of the ESMO-MCBS scores. Nicola Latino ( ESMO Scientific Affairs staff) provided coordination and support of the ESMO-MCBS scores and Angela Corstorphine and Sian-Marie Lucas of KMC provided medical writing and editing support in the preparation of the ESMO-MCBS table; this support was funded by ESMO . Dr Benedikt Westphalen (member of the ESMO Translational Research and Precision Medicine Working Group) and Dr Svetlana Jezdic ( ESMO Medical Affairs Advisor) provided validation support for ESCAT scores.

Keywords: cholangiocarcinoma, diagnosis, follow-up, gallbladder cancer, precision medicine, treatment

Local EPrints ID: 474870

URI: http://eprints.soton.ac.uk/id/eprint/474870

DOI: doi:10.1016/j.annonc.2022.10.506

ISSN: 1569-8041

PURE UUID: 8f0f0e10-eccd-4bd4-b4f1-143a007299e2

ORCID for John Primrose: orcid.org/0000-0002-2069-7605

Date deposited: 06 Mar 2023 17:33

Last modified: 17 Mar 2024 07:37